Post-dengue mucormycosis- a novel entity or COVID-19 associated in disguise?

Trop Doct. 2024 Oct;54(4):365-368. doi: 10.1177/00494755241269196. Epub 2024 Aug 12.

Abstract

Dengue is a disease endemic to tropical countries such as India. In the past two years, cases of COVID-19 associated Mucormycosis have become a commonly encountered phenomenon. However, cases of dengue associated Mucormycosis have not found a significant mention in the literature yet. We, therefore, report two such cases in which Mucormycosis developed after recovery from Dengue fever and try to dig into the possible mechanism behind such an occurrence.

Keywords: COVID-19; Mucormycosis; dengue.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • COVID-19* / complications
  • Dengue* / complications
  • Dengue* / diagnosis
  • Female
  • Humans
  • India
  • Male
  • Middle Aged
  • Mucormycosis* / diagnosis
  • SARS-CoV-2*

Substances

  • Antifungal Agents